These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6025780)
1. Variability of uniformity of weight test as an indicator of the amount of active ingredient in tablets. Airth JM; Bray DF; Radecka C J Pharm Sci; 1967 Feb; 56(2):233-5. PubMed ID: 6025780 [No Abstract] [Full Text] [Related]
2. Estimation of mean potency and content uniformity of tablets: a new approach. Comer JP; Breunig HL; Broadlick DE; Sampson CB J Pharm Sci; 1970 Feb; 59(2):210-4. PubMed ID: 5411343 [No Abstract] [Full Text] [Related]
3. [Pressure-course events in the tabletting of phenylbutazone]. Wenzel U; Kala H Pharmazie; 1984 Oct; 39(10):693-4. PubMed ID: 6522447 [TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic analysis of isoniazid and its dosage forms. Bailey LC; Abdou H J Pharm Sci; 1977 Apr; 66(4):564-7. PubMed ID: 856977 [TBL] [Abstract][Full Text] [Related]
8. Lot-to-lot variation in dissolution of tolbutamide tablets. Ayres JW Am J Hosp Pharm; 1980 Oct; 37(10):1329-32. PubMed ID: 7424928 [TBL] [Abstract][Full Text] [Related]
9. Determination of phenylbutazone in tablets by nuclear magnetic resonance spectrometry. Stromberg R J Pharm Sci; 1984 Nov; 73(11):1653-5. PubMed ID: 6520776 [TBL] [Abstract][Full Text] [Related]
10. Interactions between digitoxin and other drugs in vitro and in vivo. Solomon HM; Reich S; Spirt N; Abrams WB Ann N Y Acad Sci; 1971 Jul; 179():362-9. PubMed ID: 5285381 [No Abstract] [Full Text] [Related]
11. [The liberation of phenylbutazone from tablets]. Miseta M; Hoang Hun Manh ; Pintye-Hódi K; Szabó-Révész P; Selmeczi B Pharmazie; 1988 Oct; 43(10):697-8. PubMed ID: 3212016 [TBL] [Abstract][Full Text] [Related]
12. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice. Tahaineh LM; Gharaibeh SF J Pharm Pract; 2012 Aug; 25(4):471-6. PubMed ID: 22544621 [TBL] [Abstract][Full Text] [Related]
13. [Use of polyacrylate dispersions for nebulization of phenobarbital. 2. In vitro testing of tablets with phenobarbital polyacrylate microspheres]. Traue J; Kala H Pharmazie; 1984 May; 39(5):331-3. PubMed ID: 6473494 [TBL] [Abstract][Full Text] [Related]
14. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765 [TBL] [Abstract][Full Text] [Related]
15. The use of mass spectrometry for the identification of metabolites of phenothiazines. Duffield AM Adv Biochem Psychopharmacol; 1974; 9(0):111-7. PubMed ID: 4151759 [No Abstract] [Full Text] [Related]
16. Proton magnetic resonance spectroscopic method for determination of phenylbutazone and oxyphenbutazone in tablets. Husain S; Kifayatullah M; Rao RN J Assoc Off Anal Chem; 1988; 71(3):525-7. PubMed ID: 3391955 [TBL] [Abstract][Full Text] [Related]
17. RATES OF DISSOLUTION OF TOLBUTAMIDE TABLETS. BRUDNEY N; STEWART DJ; EUSTACE BT Can Med Assoc J; 1964 Apr; 90(16):980-1. PubMed ID: 14140001 [TBL] [Abstract][Full Text] [Related]
18. EFFECT OF DOSAGE FORM PROPERTIES ON THERAPEUTIC EFFICACY OF TOLBUTAMIDE TABLETS. LEVY G Can Med Assoc J; 1964 Apr; 90(16):978-9. PubMed ID: 14140000 [TBL] [Abstract][Full Text] [Related]
19. [The polymorphism of drugs in powders and tablets. 4. The effect of the polymorphism of drugs on the physical properties and drug release of phenobarbital tablets]. Szabó-Réveśz P; Pintye-Hódi K; Miseta M; Selmeczi B; Kedvessy G; Traue J; Kala H; Wenzel U Pharmazie; 1987 Mar; 42(3):179-81. PubMed ID: 3602074 [TBL] [Abstract][Full Text] [Related]
20. [Optimization of the composition of tablets of phenylbutazone and aminophenazone by means of trial planning]. Welikowa E; Jonowa R; Jontschew C Pharmazie; 1977; 32(8-9):502-4. PubMed ID: 594116 [No Abstract] [Full Text] [Related] [Next] [New Search]